June 19, 2008

PuriCore Presenting at the Piper Jaffray European Conference

PuriCore (LSE:PURI), the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, today announces that its Chief Executive Officer, Greg Bosch, will be presenting at the Piper Jaffray European Conference at the ANdAZ Hotel in London, on June 25, 2008. A webcast of the presentation will be available live as at 3 pm BST (10 am EDT), and replays of the webcast will be available as at 4 pm BST (11 am EDT). A link to the webcast will be available at PuriCore's investor website.

About PuriCore

PuriCore plc (LSE:PURI) is a life sciences company focused on developing and commercializing proprietary, green products that safely, effectively, and naturally kill contagious pathogens. PuriCore's technology provides a solution to a broad range of markets that depend upon controlling contamination, including food safety in retail and foodservice, medical device disinfection, wound therapy, and hospitality. The Company's proprietary technology mimics the human body's production of the natural antimicrobial hypochlorous acid, which is highly effective in killing bacteria, viruses, and fungal spores. Deploying hypochlorous acid solutions as soaks, sprays, mists, and in other forms, PuriCore's technology is designed to limit the spread of infectious disease, including major public health threats of M. tuberculosis, MRSA, E.coli, Norovirus, Avian Influenza, HIV, Polio Virus, Helicobater pylori, and Legionella. PuriCore is headquartered in Malvern, Pennsylvania, with offices in Stafford, UK.

To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.